Medifast (MED) Tops Q4 EPS by 9c, Revenues Beat; Offers EPS/Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Medifast, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results
February 26, 2019 4:16 PM ESTBALTIMORE, Feb. 26, 2019 /PRNewswire/ --Â Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, today reported financial results for the fourth quarter and full year ended December 31, 2018.
Fourth Quarter 2018 Highlights:
Revenue of $145.8 million, an increase of 87.0% year-over-year Active earning Coaches of 24,100, an increase of 60.7% year-over-year Net income of $15.7 million, an increase of 114.2%... More